Disclosures for "Masupirdine (A Pure 5-HT6 Receptor Antagonist): Clinical Development Program Targeting Agitation in Alzheimer’s Dementia – Phase-3 Study Updates"
-
Dr. Nirogi has nothing to disclose.
-
Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
-
Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
-
Vijay Benade has nothing to disclose.
-
Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Abraham has nothing to disclose.
-
Mr. Pandey has nothing to disclose.
-
Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. S has nothing to disclose.
-
Mr. Mohammed has nothing to disclose.
-
Pradeep Jayarajan has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan has stock in Suven Life Sciences. Pradeep Jayarajan has received intellectual property interests from a discovery or technology relating to health care.